Trefny, M.P.* ; Kroemer, G.* ; Zitvogel, L.* ; Kobold, S.
Metabolites as agents and targets for cancer immunotherapy.
Nat. Rev. Drug Discov., DOI: 10.1038/s41573-025-01227-z (2025)
Hadian, K. ; Stockwell, B.R.*
The therapeutic potential of targeting regulated non-apoptotic cell death.
Nat. Rev. Drug Discov. 22, 723-742 (2023)
Müller, T.D. ; Blüher, M. ; Tschöp, M.H. ; DiMarchi, R.D.*
Anti-obesity drug discovery: Advances and challenges.
Nat. Rev. Drug Discov. 21, 201-223 (2022)
Siehler, J. ; Blöchinger, A. ; Meier, M. ; Lickert, H.
Engineering islets from stem cells for advanced therapies of diabetes.
Nat. Rev. Drug Discov. 20, 920–940 (2021)
Conrad, M. ; Friedmann Angeli, J.P.F. ; Vandenabeele, P.* ; Stockwell, B.R.*
Regulated necrosis: Disease relevance and therapeutic opportunities.
Nat. Rev. Drug Discov. 15, 348-366 (2016)
von Boehmer, H.* ; Daniel, C.
Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer.
Nat. Rev. Drug Discov. 12, 51-63 (2013)